Pleurodesis for malignant pleural effusion: Talc, toxicity and where next?

Thorax

Volumn 63, Issue 7, 2008, Pages 572-574

  Davies, Helen E ^a   Lee, Y C Gary ^a,b   Davies, Robert J O ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN; PICIBANIL; POVIDONE IODINE; TALC; TRANSFORMING GROWTH FACTOR BETA;

BREAST CANCER; CLINICAL TRIAL; DRUG SAFETY; EDITORIAL; HUMAN; HYPOTENSION; HYPOXEMIA; LUNG CANCER; LUNG TOXICITY; PARTICLE SIZE; PERITONEUM PLEURA SHUNT; PLEURA EFFUSION; PLEURA MESOTHELIOMA; PLEURODESIS; PRIORITY JOURNAL; SHUNTING; THORACOCENTESIS; THORAX PAIN; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

HUMANS; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; TALC;

EID: 47049102889     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2007.092940     Document Type: Editorial

References (23)

1. Anderson CB, Philpott GW, Ferguson TB. The treatment of malignant pleural effusions. Cancer 1974;33:916-22.
2. Lee YC, Baumann MH, Maskell NA, et al. Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists. Chest 2003;124:2229-38.
3. Medical and Healthcare Products Regulatory Authority (MRHA). MHRA Statement on Talc Preparations for Pleurodesis. Ref: MDR 10-10/07 London: MRHA, 2007.
4. Maskell NA, Lee YC, Gleeson FV, et al. Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med 2004;170:377-82.
5. Ferrer J, Montes JF, Villarino MA, et al. Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis. Chest 2002;122:1018-27.
6. Kennedy L, Harley RA, Sahn SA, et al. Talc slurry pleurodesis. Pleural fluid and histologic analysis. Chest 1995;107:1707-12.
7. Werebe EC, Pazetti R, Milanez DC Jr, et al. Systemic distribution of talc after intrapleural administration in rats. Chest 1999;115:190-3.
8. Dresler CM, Olak J, Herndon JE, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005;127:909-15.
9. Wagenfeld L, Zeitz O, Richard G. Visual loss after povidone-iodine pleurodesis. N Engl J Med 2007;357:1264-5.
10. Olivares-Torres CA, Laniado-Laborin R, Chavez-Garcia C, et al. Iodopovidone pleurodesis for recurrent pleural effusions. Chest 2002;122:581-3.
11. Janssen JP, Collier G, Astoul P, et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 2007;369:1535-9.
12. Lee YC, Teixeira LR, Devin CJ, et al. Transforming growth factor-beta2 induces pleurodesis significantly faster than talc. Am J Respir Crit Care Med 2001;163:640-4.
13. Lee YC, Lane KB, Parker RE, et al. Transforming growth factor beta(2) (TGF beta(2)) produces effective pleurodesis in sheep with no systemic complications. Thorax 2000;55:1058-62.
14. Lee YC, Yasay JR, Johnson JE, et al. Comparing transforming growth factor-beta2, talc and bleomycin as pleurodesing agents in sheep. Respirology 2002;7:209-16.
15. Light RW, Cheng DS, Lee YC, et al. A single intrapleural injection of transforming growth factor-beta(2) produces an excellent pleurodesis in rabbits. Am J Respir Crit Care Med 2000;162:98-104.
16. Kishi K, Homma S, Sakamoto S, et al. Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions. Eur Respir J 2004;24:263-6.
17. Luh KT, Yang PC, Kuo SH, et al. Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial. Cancer 1992;69:674-9.
18. Ren S, Terman DS, Bohach G, et al. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer. Chest 2004;126:1529-39.
19. Tremblay A.Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest 2006;129:362-8.
20. Tremblay A, Mason C, Michaud G. Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis. Eur Respir J 2007;30:759-62.
21. Musani AI, Haas AR, Seijo L, et al. Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters. Respiration 2004;71:559-66.
22. Putnam JB Jr, Walsh GL, Swisher SG, et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 2000;69:369-75.
23. Saffran L, Ost DE, Fein AM, et al. Outpatient pleurodesis of malignant pleural effusions using a small-bore pigtail catheter. Chest 2000;118:417-21.